Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug duo aims to keep aggressive head & neck cancer at bay

NCT ID NCT05433116

Ongoing Disease control Sponsor: Universität des Saarlandes Source: ClinicalTrials.gov ↗

Summary

This study is testing if adding a pill called lenvatinib to an existing immunotherapy drug (pembrolizumab) works better than the immunotherapy alone to keep cancer from coming back. It's for adults with a specific type of advanced head and neck cancer who have just finished their initial chemo-radiation treatment. The goal is to see if the two-drug combination helps patients stay cancer-free for longer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Gemeinschaftspraxis Hämatologie-Onkologie

    Dresden, Saxony, 01307, Germany

  • Hospital Chemnitz, Radiation Oncology

    Chemnitz, Saxony, 09116, Germany

  • Saarland University Medical Center and Saarland University Faculty of Medicine, Clinic for Radiotherapy and Radiooncology

    Homburg, Saarland, 66421, Germany

  • University Hospital Augsburg, Radiation Oncology

    Augsburg, Bavaria, 86156, Germany

  • University Hospital Düsseldorf, Radiation Oncology

    Düsseldorf, North Rhine-Westphalia, 40225, Germany

  • University Hospital Erlangen, Radiation Oncology

    Erlangen, Bavaria, 91054, Germany

  • University Hospital Frankfurt/M, Center for Radiology

    Frankfurt am Main, Hesse, 60590, Germany

  • University Hospital Giessen; Ear, nose and throat clinic

    Giessen, Hesse, 35392, Germany

  • University Hospital Regensburg, Clinic and Polyclinic for Radiotherapy

    Regensburg, Bavaria, 93053, Germany

  • University Hospital Ulm, Otolaryngology & Head and Neck Surgery

    Ulm, Baden-Wurttemberg, 89070, Germany

Conditions

Explore the condition pages connected to this study.

HEAD AND NECK SQUAMOUS CELL CARCINOMA